IonQ Discloses Cambridge Collaboration Shares and Insider Sale in New SEC Filings

IonQ IONQ -2.42% ▼ filed a group of new reports with the U.S. Securities and Exchange Commission that give more detail on a recent deal with the University of Cambridge and a small insider stock sale. The filings show the quantum firm issued shares to Cambridge as part of a research tie-up and later registered those shares for sale in the public market.

Claim 70% Off TipRanks Premium

• Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions

• Stay ahead of the market with the latest news and analysis and maximize your portfolio’s potential

At the same time, a director filed notice of a small stock sale linked to pay-related share awards.

Meanwhile, IONQ shares dropped 2.42% on Wednesday, closing at $34.27.

Cambridge Collaboration and Share Registration

First, the main filing relates to shares issued to The Chancellor, Masters, and Scholars of the University of Cambridge. IonQ said the shares were issued as part of a collaboration deal signed on March 10.

In total, the company issued 2.56 million shares of common stock to Cambridge. IonQ later filed a prospectus that allows Cambridge to sell those shares in the market if it chooses.

However, the company made clear that it will not get cash from those sales. As the filing states, “We will not receive any proceeds from the sale of shares of our common stock by the selling stockholder.”

In other words, the shares were already granted under the deal. The new filing only allows Cambridge to sell them later through normal market trades.

Even so, the stake is small compared with IonQ’s full share count of more than 366 million. As a result, the deal’s potential market supply remains limited.

Director Files Small Stock Sale

Meanwhile, a separate filing shows that IonQ director Robert T. Cardillo plans to sell 1,000 shares of stock. The filing says the shares came from performance stock units that recently vested. It also states the sale is meant to cover tax costs tied to those awards. Such sales are common when stock-based pay vests, since firms often require tax withholding at the time the shares are issued.

In addition, the company filed several power-of-attorney forms. These give IonQ legal and finance staff the right to file ownership reports with the SEC on behalf of company leaders.

These reports include Forms 3, 4, 5, and 144, which track stock held or sold by company insiders.

Overall, the filings point to a mix of routine insider paperwork and a small tax-related stock sale. More notably, they also confirm IonQ’s use of stock as part of a research deal with the University of Cambridge as the company builds ties with major science groups in the field of quantum tech.

Is IONQ Stock a Buy?

On the Street, IonQ holds a Moderate Buy consensus rating. The average IONQ stock price target stands at $64.40, implying a 87.92% upside from the current price.

Disclaimer & DisclosureReport an Issue